Pharmaceutics International, Inc. (Pii) has successfully completed its first US-based inspections by the European Medicines Agency (EMA) and FDA. The four-day inspection was conducted by the agencies as part of a joint initiative focused on increasing international regulatory collaboration among the agencies to enhance global drug quality and safety. “Our entire team is very proud of the successful outcome of the joint FDA/EMA inspection,” said Tony Horton, vice president of quality...